Creadd Ventures
Creadd Ventures is a Swiss venture capital firm investing in pre-growth and growth-stage Healthcare, DeepTech, and SaaS B2B companies in Switzerland and Europe, with tickets of 2-30 million CHF at Series A+ and Series B stages.
- Company typePrivate
- Founded2012
- HeadquartersLugano, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Creadd Ventures does
Creadd Ventures (legal entity CREADD SA) is a privately-held Swiss venture capital firm headquartered in Lugano, Switzerland. The firm invests in pre-growth and growth-stage companies developing disruptive technologies across three core verticals: Healthcare (biotech, medtech, digital biology), DeepTech (advanced materials, AI-driven solutions, semiconductors, platform technologies), and SaaS B2B (full-stack solutions with domain expertise). Ticket sizes are 2-10 million CHF at Series A+ and 10-30 million CHF at Series B, targeting enterprise values of 8-30 million CHF and 30-100 million CHF respectively, with an expected 3-5 year liquidity window.
The firm is led by Managing Partners Lorenzo Leoni PhD (University of Lausanne; founder of Salmedix and Telormedix in biotech) and Paolo Orsatti PhD (ETH Zurich; founder of Nemerix, acquired by Qualcomm in 2009), supported by Partners Attilio Baggerman and Rie My-Morozumi. Creadd evolved from TiVentures (established 2016) and the founders' prior roles at the Agire Foundation (Canton Ticino's Innovation Agency, 2012-2016). The team has continuously invested in Swiss and European technology companies since 2012, with a seed-stage track record of MOIC >2 and DPI 0.5 across more than 20 investments via TiVentures.
Creadd generates returns through equity investments and realized exits rather than recurring fees at scale. Its core value proposition is company-building rather than passive capital provision: portfolio companies receive board-level engagement, operational mentorship, and access to a network spanning ETH Zurich, EPFL, institutional investors, and co-investment partners. The current disclosed portfolio includes Aesyra (sleep health, EPFL spinout), xFarm (agtech), Delvitech (AI-native optical inspection), Hexl, and Hive Power. Recent activity includes co-leading Delvitech's $40 million Series B in November 2025.
Creadd Ventures firmographics
Firmographics- Name
- Creadd Ventures
- Legal name
- CREADD SA
- Website
- https://creadd.ch
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Creadd Ventures is a Swiss venture capital firm investing in pre-growth and growth-stage Healthcare, DeepTech, and SaaS B2B companies in Switzerland and Europe, with tickets of 2-30 million CHF at Series A+ and Series B stages.
- Ownership category
- akta.pro rank
Creadd Ventures industry classification
Industry- Product category
- Venture Capital
- NAICS
- Miscellaneous Financial Investment Activities (523999)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Venture Capital Fund-of-Funds (FSANAGAC)
Keywords
Where Creadd Ventures is headquartered
LocationHeadquarters
- HQ city
- Lugano
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Creadd Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Investment Returns and Carried Interest: Creadd Ventures generates returns through equity investments in portfolio companies, realizing gains through exits including IPOs and acquisitions. Their investment approach targets 2-10 Mio CHF at Series A+ stage and 10-30 Mio CHF at Series B, seeking to generate liquidity within 3-5 years.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Creadd Ventures product offering
Product offeringCore offering
Creadd Ventures is a Swiss venture capital firm that makes direct equity investments in pre-growth (Series A+) and growth-stage (Series B) companies developing disruptive technologies across Healthcare, DeepTech, and SaaS B2B sectors. The firm invests 2-10 million CHF at Series A+ and 10-30 million CHF at Series B, providing company-building support, board participation, and operational guidance alongside capital.
Product overview
CREADD Ventures is a Swiss venture capital firm that invests in pre-growth and growth companies developing disruptive technologies across Healthcare, Deeptech, and SaaS B2B sectors. The firm focuses on early growth (Series A+) and growth stage (Series B) companies, typically investing 2–10 million CHF in early growth and 10–30 million CHF in growth rounds. CREADD Ventures provides company-building support including entrepreneurial, managerial, and technical expertise rather than operating a product or technology platform of its own. Their portfolio includes companies such as Delvitech (AI-powered optical inspection for electronics), Aesyra (sleep health technology), xFarm (agricultural technology), Hexl, and Hive Power.
Differentiator
Problem solved
Functional benefit
Products and services
- Pre-growth (Series A+) Investment Equity investment service targeting pre-growth stage companies developing disruptive technologies across Healthcare, DeepTech, and SaaS B2B sectors. Typical check size is 2-10 million CHF at Series A+, with enterprise value targets of 8-30 million CHF and an expected 3-5 year liquidity window. Includes company-building support, board memberships, and access to co-investor networks.
- Growth-stage (Series B) Investment Equity investment service targeting growth-stage companies with existing market traction and well-defined expansion strategies. Typical check size is 10-30 million CHF at Series B, with enterprise value targets of 30-100 million CHF and an expected 3-5 year liquidity window. Includes board-level governance support and strategic guidance for global scaling.
Quantifiable outcome
- Seed investments MOIC >2, DPI 0.5
- +2 more outcomes
Companies that use Creadd Ventures
Customer profileSegments3 records
Ideal customer profiles3 records
Creadd Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Creadd Ventures partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights6 records
Creadd Ventures competitors and assessment
Company assessmentDirect peers
- btov Partners: Swiss/European early-stage venture firm investing across digital, deep tech, and industrial tech. Closest comparable in stage, geography, and thesis of bridging European university spinouts with operational support.
- Emerald Technology Ventures: European VC focused on industrial tech, clean tech, and deep tech. Comparable in stage and sector overlap, especially in advanced materials and industrial AI.
- Amadeus Capital Partners: European DeepTech venture firm with deep semiconductor, AI, and healthcare expertise. Comparable sector focus and operator-investor approach.
- HTGF (High-Tech Gründerfonds): Germany-based DeepTech and industrial tech seed/Series A investor with strong university spinout pipeline. Comparable in stage, sector mix, and company-building model.
- Polytech Ventures: Swiss/European early-stage VC with strong EPFL network. Comparable stage and sector focus on deep tech and industrial ventures sourced from Swiss universities.
- VI Partners: Swiss venture capital firm investing in early- and growth-stage technology and healthcare companies. Directly comparable geographic focus and sector overlap (DeepTech, Healthcare).
Broad incumbents
- Earlybird Venture Capital: Established European early-stage VC with strong DeepTech and Health franchises. Comparable sector focus, broader geographic reach, and longer track record than Creadd.
- Speedinvest: Large European early-stage VC with sector-dedicated funds including DeepTech and Health. Comparable in sector coverage but operates at materially larger fund scale.
- Index Ventures: Major European-origin VC investing from seed to growth across tech and healthcare. Represents the competitive ceiling — operating at scale Creadd aspires toward, with overlapping Swiss/European deal flow.
Regional players
- Swisscom Ventures: Corporate venture arm of Swisscom, investing in Swiss/European growth-stage tech and digital health. Comparable regional footprint and stage, though strategically tied to a strategic parent.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Creadd Ventures social profiles
Digital presenceCreadd Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Creadd Ventures leadership team
Management profileNumber of profiles
Profiles4 records
Creadd Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Creadd Ventures M&A and investment
M&A and investmentM&A
Investments9 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Creadd Ventures
What does Creadd Ventures do?
Creadd Ventures is a Swiss venture capital firm that makes direct equity investments in pre-growth (Series A+) and growth-stage (Series B) companies developing disruptive technologies across Healthcare, DeepTech, and SaaS B2B sectors. The firm invests 2-10 million CHF at Series A+ and 10-30 million CHF at Series B, providing company-building support, board participation, and operational guidance alongside capital.
Is Creadd Ventures a public or private company?
Creadd Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Creadd Ventures founded?
Creadd Ventures was founded in 2012. It employs 1 to 10 people.
Where is Creadd Ventures based?
Creadd Ventures is headquartered in Lugano, Switzerland, in the Europe region.
How does Creadd Ventures make money?
One revenue line is on record: investment Returns and Carried Interest.
Who are Creadd Ventures's main competitors?
Direct peers on record are btov Partners, Emerald Technology Ventures, Amadeus Capital Partners, HTGF (High-Tech Gründerfonds), Polytech Ventures and VI Partners. Broad incumbents are Earlybird Venture Capital, Speedinvest and Index Ventures. Swisscom Ventures is listed as a regional player.
Does Creadd Ventures have an API?
No public API is recorded for Creadd Ventures.
What industry is Creadd Ventures in?
Creadd Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAGAC, Venture Capital Fund-of-Funds. Its NAICS code is 523999 and its SIC code is 6282.